vimarsana.com

Latest Breaking News On - Neximmune inc - Page 4 : vimarsana.com

NexImmune Announces $3 67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

GAITHERSBURG, Md., Feb. 02, 2024 NexImmune, Inc. a biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function.

NexImmune Announces $3 67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

GAITHERSBURG, Md., Feb. 02, 2024 NexImmune, Inc. a biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function.

Why CommScope Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Monday s Mid-Day Session - Archer-Daniels Midland (NYSE:ADM), Aclaris Therapeutics (NASDAQ:ACRS)

Shares of CommScope Holding Company, Inc. (NASDAQ: COMM) fell sharply during Monday’s session. B of A Securities analyst Tal Liani downgraded CommScope from Neutral to Underperform and lowered the price target from $2.1 to $2. CommScope shares dipped 6.9% to $2.2150 on Monday.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.